Introduction
Various genetically encoded programs involved in signaling or in the initiation of cell death may decide the fate of individual cells or organs during development. The term 'programmed cell death' has therefore been used primarily to describe the coordinated series of events leading to controlled cell demise in developing organisms . Owing to this early definition, the term 'physiological cell death' has been linked to the notion of 'programmed cell death.' Nevertheless, cells execute a biochemical program of cell death also under pathological conditions, and the consequences for the individual cell may be practically indistinguishable from those observed during developmental demise. In many circumstances, developmental cell death as well as death under pathological conditions have the morphological characteristics described by Lockshin and Williams (1965) and by Kerr et al. (1972) . The concept of a death program is, however, not necessarily linked to a morphological appearance. For example, in non-vertebrate systems, programmed cell death does not always display an apoptotic-like morphology . This is the reason why the early pioneering work in Caenorrhabditis elegans did not describe developmental cell death in C. elegans as apoptotic (Yuan and Horvitz, 1990) . Nevertheless, the discovery that both developmental and nondevelopmental death can share similar execution systems and controlling proteins blurred the boundary between developmental cell death and cell demise in adult tissues. In particular, the characterization of the main executioners of apoptosis, the caspases, has linked the physiological type of death encountered in development with that observed in pathological situations throughout the whole life span. This has focused attention on the molecular mechanisms of apoptosis with less attention to distinct cell death paradigms. For example, a second type of regulated, active cell death is autophagic cell death, which is characterized by the appearance of cytoplasmic autophagic vacuoles originating from lysosomes, followed by mitochondrial dilatation and enlargement of the ER and Golgi (Schweichel and Merker, 1973) . Autophagic death is frequent in neuronal development and in neurodegenerative diseases (Petersen et al., 2001; Yuan et al., 2003) . In 1990, Clarke (1990) also described a third model of cell death with vacuolar degeneration, swelling of intracellular organelles, without lysosomal activation. This model of cell death, also found in the developmental neuronal system, is similar to necrosis. Finally, although neglected by most, cell lysis/necrosis can also be regulated and may involve in some cases caspase activation (Schwab et al., 2002) .
All these types of cell death are present and strictly regulated in vivo. This is evident, for example, in C. elegans (Xu et al., 2001; Suzuki et al., 2003) . Here, specific aspartyl and calpain proteases are required for neurodegeneration (Syntichaki et al., 2002) . This poses several relevant questions: (i) What are the factors that determine the choice between different types of death? (ii) Do different programs only represent death subroutines, which target preferentially subsets of cells or event intracellular targets? (iii) When do they intervene together to eliminate damaged cells in vivo?
Here, we shall outline some molecular mechanisms that are known to switch cells' fate from apoptosis to necrosis or vice versa, and discuss their relevance in pathological settings.
Caspase-dependent cell death
The finding that one class of death-related genes, those expressing caspases (cysteine aspartases) (Nicholson, 1999) , are involved in cell death in genetically distant organisms has directed attention on the central role of this protease family as the main effector of apoptotic cell demise. Consequently, there is a tendency to identify apoptosis conceptually with its main execution system. Caspases are constitutively expressed in mammals, similar to ced-3 in C. elegans (Shaham and Horvitz, 1996) . To date, at least 13 human caspases have been identified. They are expressed as inactive proenzymes and proteolytically activated to form active tetramers. Substrates include cytoskeletal proteins, nuclear structural proteins and enzymes, and some controllers of caspase activation (i.e. Bcl-2) (Nicholson, 1999) . However, some caspases may eventually have death-unrelated, and perhaps vital functions and their activation may not always underlie cell death. Caspase multiplicity likely reflects their diverse roles under pathophysiological conditions. For example, caspases degrade amyloid precursor protein, presenilins (PS1, PS2), tau, huntingtin, atrophin-1, ataxin-3 and the androgen receptor (Ellerby et al., 1997; Gervais et al., 1999) . However, cleavage of relevant substrates does not necessarily imply that caspase activation is the major mechanism leading to cell death in pathological settings. It is indeed unlikely that a single execution system, even as diversified as the one involving caspases, is alone responsible for death execution. Should this be the case, viruses and transformed cells could have easily escaped or shut down a program converging on a single execution pathway. These considerations may help to understand why different sets of caspases are recruited in different paradigms of mammalian cell death, and also why deletion of single caspases has only localized and partial effects on cell death (Kuida et al., 1996 (Kuida et al., , 1998 . Moreover, several forms of demise seem to be caspase independent (Sarin et al., 1997) or even accelerated by caspase inhibitors (Vercammen et al., 1998a, b) . Indeed, other protease families have been implicated in apoptosis (Adjei et al., 1996; Grimm et al., 1996) , while caspases can be activated without causing cell death (Jaattela et al., 1998) . In some cases, caspase inhibition does not alter the extent of death, but rather the shape of demise (Hirsch et al., 1997; Leist et al., 1997) .
The degree of caspase activation may also be of importance. Caspase activation varies quantitatively from system to system, and it is unclear whether a threshold has to be reached to turn caspase activation into a lethal reaction. For example, a moderate degree of caspase activation does not always cause cell demise (Jaattela et al., 1998) . Finally, an apoptotic-like death can also occur in a caspase-independent manner (see, for review, Borner and Monney, 1999) . Part of the problem may be due to the fact that caspase inhibitors can prevent the appearance of certain, but not all, features of apoptosis in certain model systems (McCarthy et al., 1997) . In this context, caution should be exercised, because of possible nonspecific effects of broad-range caspase inhibitors. Although generally considered specific for the caspase family, these inhibitory peptides may in fact block only some, but not all, caspases. It is also clear that caspase inhibitors can also inhibit unrelated proteases, whose activity may be necessary for survival. While the existence of alternative pathways may be conceivable, to date, the evidence for effective alternative execution systems is limited. The crosstalk between caspases and other proteases is also worth considering in this context. In particular, calpains, and also other proteases can synergize or in contrast hinder caspases in the execution of cell death. Notably, recent work suggests that caspases can also trigger secondary necrosis when they cleave and inactivate plasma membrane Ca 2 þ transport systems. This causes secondary Ca 2 þ overload and plasma membrane lysis (Schwab et al., 2002) .
Energy requirement for the shape of cell death
While the occurrence of a caspase-independent apoptosis is strongly debated, it is instead widely accepted that, in some cases, caspase inhibitors only delay cell demise. Cells die eventually with morphologically different characteristics (Hirsch et al., 1997; Leist et al., 1997) . Evidence that cells triggered to undergo apoptosis are instead forced to die by necrosis when energy levels are rapidly compromised has been recently provided (Leist et al., 1997) , see Figure 1 .
In vivo, under pathological conditions, apoptosis and necrosis may often coexist (Leist et al., 1995) . Moreover, Figure 1 Apoptosis-necrosis switch by ATP. Switch of the morphology of cell death, shown by electron microscopy, and its regulation by the intracellular ATP concentration levels Regulation of the apoptosis-necrosis switch P Nicotera and G Melino intracellular energy levels are rapidly dissipated in necrosis, but not in apoptosis (Ankarcrona et al., 1994) . By manipulating the intracellular adenosine triphosphate (ATP) level, it has been possible to determine that when intracellular ATP is low, typical apoptotic stimuli cause necrosis (Leist et al., 1997) . ATP can be either depleted or repleted to defined levels and for defined periods of time. This allows identification of a defined period of time after the exposure of cells to apoptogenic stimuli during which energydependent steps are required to complete the apoptotic program. If ATP concentrations are markedly reduced during this period, activation of downstream caspases and all typical apoptotic features are blocked. Stimulated cells die nonetheless. However, death has a necrotic appearance. These findings provide direct evidence that the complete apoptotic program involves energy-requiring steps, one of which is at the level of the formation of the protein complex between Apaf-1, cytochrome c (cyt c) and procaspases , outlined in Figure 2 . Lack of ATP at this step would prevent the resulting downstream degradative processes including caspase-3 activation.
Nitric oxide (NO) as an inhibitor or activator of apoptosis and molecular switch between apoptosis and necrosis NO is a second messenger molecule with the unique property, being a gas, of freely moving from one cell to the other (Moncada et al., 1991; Bredt and Snyder, 1994) . In fact, NO is an extremely versatile messenger in biological systems, and has been implicated in a number of different physiopathological roles, such as smooth muscle relaxation, platelet inhibition, neurotransmission, immune regulation, cell differentiation and tissue morphogenesis (Stamler and Piantadosi, 1996; Stamler et al., 1997; Brune et al., 1999; Nicotera et al., 1999a; Gu et al., 2002) and cytotoxicity (Brune et al., 1999) . Cell death elicited by endogenously derived NO plays a central role in pathologic phenomena such as septic shock, nonspecific 'host' defense against tumors and intracellular pathogens, acute and chronic neurodegenerative diseases, pancreatic b-cell destruction in diabetes mellitus and transplant rejection (Choi, 1988; Moncada et al., 1991; Bredt and Snyder, 1994; Kaneto et al., 1995; Bonfoco et al., 1996; Nicotera et al., 1997 Nicotera et al., , 1999b Leist and Nicotera, 1998) . Figure 3 shows a schematic pattern of the action of NO, from its synthesis, chemical interactions, intracellular biochemical effectors, leading to its biological actions.
NO is a hydrophobic molecule and a highly diffusible free radical, generated from the oxidation of L-arginine to L-citrulline by a family of constitutive or cytokineinducible nictotinamide adenine dinucleotide phosphate-dependent isoenzymes, the NO synthases (NOS) (part 2 in Figure 3 ). Neuronal NOS (nNOS) and endothelial NOS (eNOS) are usually constitutively expressed in selective tissues, and are transiently activated by an increase in intracellular concentration of free Ca 2 þ . On the contrary, the cytokine-inducible NOS (iNOS) is transcriptionally regulated, resulting in NO production at basal Ca 2 þ levels for up to several days (Nicotera et al., 1999a) . Following its production, NO is preserved in its molecular structure by a chemically heterogeneous group of spontaneously decomposing NO donors (part 3 in Figure 3 ). This deposit stabilization finely tunes the biological activity of NO after its liberation.
NO is highly reactive (see part 3 in Figure 3 ), and its half-life is extremely short in biological systems, being estimated below microseconds. The chemistry of NO involves inter-related redox forms (NO , NO þ , NO À ), with different chemical reactivity toward distinct target groups, thus explaining the pleiotropic effects of NO in biological systems (see Figure 3) (Stamler et al., 1992a, b) . NO reacts with molecular oxygen, superoxide anion and transition metal cations, leading to the formation of reactive nitrogen intermediates that Regulation of the apoptosis-necrosis switch P Nicotera and G Melino directly or indirectly support additional nitrosative reactions (Figure 3 ). In particular, NO binds to hemoproteins and iron-sulfur centers. The nitrosonium cation (NO þ ) character found in nitroso compounds in biological systems is involved in nitrosation reactions with nucleophilic groups such as thiols, amines, carboxyls, hydroxyls, and aromatic rings (Figure 3) . The nitroxyl anion (NO À ) rapidly undergoes dimerization and dehydration, thus generating dinitrogen oxide, in addition to reacting with thiols leading to sulfhydryl oxidation and with metals (Figure 3) .
NO-mediated intracellular signaling pathways can be mediate by cyclic guanylic acid (cGMP) (Figure 3) ; cGMP formation results from NO binding to the heme group of soluble guanylyl cyclase, thus leading to enzyme activation. Alternatively, cGMP-independent mechanisms include inhibition of iron-sulfur centers, DNA damage, poly(adenosine 5%-diphosphate-ribosylation) activation with cellular energy deprivation and protein modification due to S-nitrosylation of thiol groups, thiol oxidation to sulfenic and sulfinic acid and tyrosine nitration (Stamler, 1994; Becker et al., 1998; Stamler and Hausladen, 1998; Foster et al., 2003) . cGMP-independent NO-induced responses account for the antimicrobial, cytostatic and cytotoxic ability of NO. S-nitrosylation of cysteine residues is a common protein modification achieved by NO in the presence of oxygen and is usually associated with the loss of protein function (Hess et al., 2001; Matsumoto et al., 2003) .
S-nitrosylation may regulate cellular signal transduction by influencing signaling proteins such as p21ras (Lander et al., 1995) and c-Jun N-terminal kinase 2 (So et al., 1998). It affects the cellular gene transcription machinery by inhibiting the DNA-binding activity of nuclear factor kB (NF-kB) (Matthews et al., 1996; Marshall and Stamler, 2001 ) and activator protein-1 (AP-1) (Tabuchi et al., 1994) or by activation of OxyR (Hausladen et al., 1996) . NO nitrosylates thiol groups of cytosolic enzymes such as transglutaminase (Melino et al., 1997; Bernassola et al., 1999; Rossi et al., 2000) , AP-1 Melino et al., 2000a) , caspases (Dimmeler et al., 1997; Melino et al., 1997) , glyceraldehyde-3-phosphate dehydrogenase (Mohr et al., 1996) hemoglobin (Jia et al., 1996; Gow and Stamler, 1998) and skeletal muscle (Stamler and Meissner, 2001; Eu et al., 2003) , and it can modulate the biological activity of extracellular molecules such as coagulation factor XIII (Catani et al., 1998) .
In addition to regulating directly the 'apoptotic' machinery, see Figure 4 , NO finely regulates the NMDA receptors, and therefore excitotoxicity in neuronal cells (Lipton et al., 1993) , including neuroblastoma cells exposed to the gp120 HIV protein (Corasaniti et al., 1992 (Corasaniti et al., , 1994 (Corasaniti et al., , 1995 Bagetta et al., 1993; Clementi et al., 1996; Maccarrone et al., 2000) , or even tamoxifen (Maccarrone et al., 1998) or fenretinide (Lovat et al., 2003) . Via S-nitrosylation or nitration of proteins, NO can be a bifunctional modulator of cell death capable of either triggering or inhibiting cell demise. In addition, NO can regulate the apoptosis-necrosis switch.
Mechanisms of NO inhibition of cell death

S-nitrosylation
NO can inhibit apoptosis. Figure 4 shows the ability of NO donors to inhibit receptor-mediated cell death. This was first demonstrated in neuronal cells during excitotoxicity (Lipton et al., 1993) . NO can also inhibit cell death in endothelial cells (Dimmeler et al., 1997) and in lymphoid cells (Mannick et al., 1994; Melino et al., 1997) . S-nitrosylation of several critical factors may be important for cell survival. S-nitrosylation of the Nmethyl-D-aspartate receptor reduces neuronal demise due to excitotoxicity (Lipton et al., 1993; Kim et al., 1999; Lipton, 1999; Bossy-Wetzel and Lipton, 2003; Manabe and Lipton, 2003) . The apoptosis execution pathway can also be interrupted by NO at different steps. Figure 4 shows several protein targets of the apoptotic machinery, which can be inhibited by NO through direct S-nitrosylation of catalytic cysteine residues. NO may interfere with the downstream apoptotic machinery acting either at the level of the executioner caspases or upstream of these events to inhibit initiator caspases such as caspase-8 and transcriptional factors such as AP-1 and NF-kB. The action of NO could therefore differ in distinct cells, depending on the specific pathway activated.
For example, exogenous NO can inhibit CD95 signaling in Jurkat T or endothelial cells via Snitrosylation of caspase-3-like proteases (Melino et al., 1997) . Other studies have shown NO-mediated inactivation of caspases in apoptotic models such as CD95-ligated human leukocytes (Mannick et al., 1997; Mannick et al., 1999) and tumor necrosis factor a (TNFa)-, proatherosclerotic factor-, and reactive oxygen species (ROS)-stimulated rat hepatocytes and endothelial cell lines (Kim et al., 1997a; Dimmeler and Zeiher, 1999; Li and Billiar, 1999) . The effects of NO can directly inhibit caspase activity by S-nitrosylation of the active-site cysteine residue (Li et al., 1997; Melino et al., 1997) . NO is also able to suppress a mechanism for the initiation or amplification of apoptotic signaling. Kim et al. (1998) have reported that both Bcl-2 cleavage and cyt c release are inhibited in TNFa-and actinomy- Figure 4 Interaction of NO with the apoptotic molecular machinery. NO has been shown to interact and regulate different steps in the apoptotic pathway: death receptor signaling, mitochondrial sensitivity, transcription factors and caspase activation. This regulation is able to alter the sensitivity of the cell to die Regulation of the apoptosis-necrosis switch P Nicotera and G Melino cin D-treated MCF-7 adenocarcinoma cells exposed to NO donors. Finally, NO can deplete mitochondrial ATP generation and thereby switch apoptosis into necrosis (see below). Interestingly, caspase zymogens are endogenously S-nitrosylated in nonstimulated human lymphocyte cell lines, and CD95 ligation can activate caspase-3 also by stimulating the denitrosylation of its catalytic site cysteine Mannick et al., 1999) .
NO as a scavenger of radical species NO can be protective against cellular damage resulting from cerebral and myocardial ischemia : reperfusion. NO exerts this protective action through the reaction with alkoxyl and peroxyl radicals, thus inhibiting lipid peroxidation (Rubbo et al., 1994) ; it also suppresses the superoxide : hydrogen peroxide-mediated cytotoxic effect by acting as a scavenger of ROS (Wink et al., 1993; Brune et al., 1997; Enikolopov et al., 1999) .
Induction of protective proteins
Exogenous NO or preinduction of iNOS has been shown to stimulate the expression of the inducible heatshock protein 70 (Hsp70) and subsequently prevent hepatocytes from TNFa-and actinomycin D-induced apoptosis (Kim et al., 1997a) . Even though it has been recently suggested that Hsp70 acts downstream of caspase activation (Jaattela et al., 1998) , the mechanisms through which it suppresses apoptosis remain largely unknown. NO can also inhibit cell death by inducing the expression of other protective proteins such as cyclooxygenase-2 (Brune et al., 1999) , hemeoxygenase-1 (Kim et al., 1995) and metallothionein . Recent studies have demonstrated that protection from ultraviolet-A-induced apoptosis is strongly correlated with NO-elicited upregulation of Bcl-2 expression (Suschek et al., 1999) .
cGMP-dependent mechanisms
In hepatocytes, NO prevents increases in caspase activity by a cGMP-dependent mechanism that does not involve S-nitrosylation (Kim et al., 1997b; Li and Billiar, 1999) . Furthermore, eNOS activation, which exerts a protective effect on the susceptibility of activated T-lymphocytes to CD95-triggered apoptosis, acts via cGMP-dependent pathways (Sciorati et al., 1997) . The effect of cGMP on apoptosis seems to be mediated through cGMP-dependent kinase (Kim et al., 1997b) .
Inhibition of ANT
NO can directly regulate the activity of the ANT mitochondrial protein, crucial for the activation of mitochondrial depolarization in certain apoptosis models (Vieira et al., 2001) . Therefore, NO can directly regulate the threshold of release of mitochondrial proteins such as cyt c, AIF, Omi/HtrA2 and Diablo/ Smac, thus finely tuning apoptosis.
Induction of cell death by NO
While the reactions described above can inhibit the execution of cell death, NO can also cause cell death. NO is implicated in both apoptotic and necrotic cell death depending on the NO chemistry and the cellular biological redox state. Also, exposure to different levels of NO can produce different outcomes: high NO levels in neurons trigger necrosis, while longer exposure to lower NO concentrations can trigger apoptosis (Bonfoco et al., 1995) , see Figure 4a . The reactivity of NO, Figure 1 , is the key to understanding when and how NO causes death or survival, Figure 4b , but its intrinsic complexity makes it difficult to pinpoint a specific chemical species
, with a direct biochemical reaction (Snitrosylation, ROS reactions, Fe-heme binding, mitochondrial DF and ATP regulation) and the biological effect (survival, apoptosis, necrosis).
NO-induced apoptosis
NO induces apoptosis in a variety of cell types, including macrophages (Brune et al., 1999) , neurons (Bonfoco et al., 1995) , pancreatic b cells (Ankarcrona et al., 1994; Kaneto et al., 1995) , thymocytes (Fehsel et al., 1995) , chondrocytes (Blanco et al., 1995) and hepatocytes (Leist et al., 1995) . The signaling pathways that lead to apoptosis still remain poorly understood. NO-induced apoptosis is often accompanied by accumulation of the tumor suppressor gene p53, changes in the expression of pro-and antiapoptotic Bcl-2 family members, caspase-3-like protease activation and cyt c translocation (Brune et al., 1999) . This is mediated by a chemical interaction with mdm2, which fails to degrade and inactivate p53 (Wang et al., 2002 (Wang et al., , 2003 Schneiderhan et al., 2003) . In the excitotoxic death of cultured neurons, NO-triggered apoptosis requires a Ca 2 þ signal triggered by the activation of the NMDAR channels (Bonfoco et al., 1996) . Depletion of ATP in PC12 cells, caused via the NO-mediated inhibition of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase, is one of the mechanisms responsible for NO neurotoxicity (Yasuda et al., 1998) . However, the NO-mediated modification glyceraldehyde-3-phosphate dehydrogenase modification cannot necessarily be linked to energy depletion, at least in monocytic macrophage cell lines (Messmer and Brune, 1996) .
Mechanisms of NO-mediated necrosis
NO induces necrosis in several cell systems via multiple target interactions, with thiol groups, heme, iron-sulfur and tyrosine residues containing proteins and DNA, and have been implicated in NO-mediated necrosis ( Figure  5a and b) . Some of these effects may be direct, whereas others may arise from the reaction of NO with superoxide anion and, at high concentrations, with oxygen to form peroxynitrite (ONOO À ) and nitrosative agents, respectively. As stated above, NO high concentrations or short time inhibit essential cellular processes, such as DNA synthesis, mitochondrial respiration and metabolic Regulation of the apoptosis-necrosis switch P Nicotera and G Melino reactions (Figure 4 and 5) . Thus, NO reacts with ribonucleotide reductase, targeting both thiol groups and the tyrosyl-free radical required for catalysis, inhibiting deoxyribonucleotide synthesis (Roy et al., 1995) . NO can disrupt mitochondrial function by reversibly inactivating cyt c oxidase, thus stimulating superoxide anion production by the respiratory chain (Cleeter et al., 1994) . The resulting superoxide anion, through the formation of ONOO À , irreversibly inhibits complexes I and III of the mitochondrial electron transport chain (Bolanos et al., 1995) . It also inactivates crucial metabolic enzymes such as aconitase, by forming iron-nitrosyl complexes with its Fe-S centers. Even though inhibition of aconitase does not necessarily induce ATP depletion depending on the cell model, it may lead to a reduction in glucose and amino-acid metabolism and subsequent energy loss (Welsh et al., 1991) .
NO therefore seems to kill via ONOO À -mediated pathways. ONOO À causes lipid peroxidation (Radi et al., 1991) , chemical cleavage of DNA (Salgo et al., 1995) and nitration of both free and protein-bound tyrosine with subsequent alterations of protein phosphorylation or perturbation of protein tertiary structure. ONOOÀ seems to contribute to cell death through the activation of the nuclear enzyme poly(adenosine 5%-diphosphoribose) synthetase, which in turn results in ATP depletion (Zhang et al., 1994) . It is not clear as to whether this is the primary mechanism of NO-induced necrosis.
NO shifts the apoptotic response elicited by different stimuli into necrotic cell death
The combined exposure of Jurkat T cells to an agonist anti-CD95 antibody and increasing concentrations of SNAP prevent apoptosis (Melino et al., 1997) . Inhibition of apoptosis and the shift to necrosis in Jurkat and neuronal cells (Volbracht et al., 2001) can occur by NO-mediated ATP depletion or by directly preventing caspases activation (Melino et al., 1997) . It is evident from these results that NO can control the switch from apoptosis into necrosis.
In neuronal apoptosis, NO can have unique features. While it can trigger glutamate release and excitotoxic cell death, NO can also prevent caspases activation and switch cell death from apoptosis into necrosis. This may be relevant in neurodegeneration when a persistent proinflammatory condition may cause sustained generation of NO. Neurons exposed to a microtubuledisassembling agent, colchicine die by apoptosis (Volbracht et al., 1999) . However, if ATP is depleted by NO, cell death occurs by necrosis. ATP depletion prevents in this system both the activation of caspases and the exposure of phagocytosis-recognition molecules.
Conclusions
It is perhaps not surprising that initially simple death programs, developed early during phylogeny, undergo complex modifications in mammalian cells. Large gene families have evolved to provide a more intricate control of cell death in higher organisms, in part, perhaps to accommodate the need of individual organ differentiation. A consequence of the increased complexity may be that an increasing number of feedback loops gives rise to multiple possibilities of initiation, control and execution. The main implication of this standpoint is the exclusion of a single, predominant commitment step. It seems likely that accumulation of damage incompatible with cell survival would require disruption of several vital cell functions. Once such a threshold is trespassed, multiple positive feedback loops would ensure the progression of (Stamler, 1994; Stamler and Hausladen, 1998; Stamler et al., , 1992a Stamler et al., , b, 1997 Stamler and Piantadosi, 1996; ) proposed that while reversible reactions are related to signaling, therefore to the life of the cell, irreversible reactions result in toxic effects. These chemical mechanisms are responsible for the biological effects outlined in Figure 5 Regulation of the apoptosis-necrosis switch P Nicotera and G Melino the death program to the end, and the safe disposal of the injured cell. This also implies that the morphological appearance of cell death (apoptosis or necrosis) is not linked to a single commitment point, but rather is a result of a more or less complete execution of subroutines deciding on the shape of dying cells. Physiological mediators such as NO have emerged as potent modulators of death pathways (Melino et al., 1997 (Melino et al., , 2000b Brune et al., 1999; Li and Billiar, 1999; Nicotera et al., 1999a) and may act as effective switches between cell death paradigms in vivo. The ability of NO to diffuse intracellularly rapidly and from cell to cell would represent an efficient mechanism to prevent the activation of apoptotic effector molecules such as caspases, resulting from cell injury or exposure to other activators (CD95L, TNFa, ceramides, retinoids, chemotherapeutic drugs). Alternatively, the ability of NO to prevent apoptosis may decide the degree of inflammation in pathological states. Finally, NO can induce cell death depending on the biological milieu, its redox state, concentration, exposure time and the combination with oxygen, superoxide and other molecules. One way to look at the pathophysiologically relevant switches between apoptosis and necrosis has been suggested by Stamler (Stamler et al., 1992a Stamler, 1994; Stamler and Piantadosi, 1996; Stamler and Hausladen, 1998) , who conceptually separate reversible NO reactions, involved in signaling, from nonreversible NO reactions, involved in toxicity (Figure 6 ). Regardless of the mediator or tissue condition that may decide the switch between different cell death modes, it is apparent that targeting individual death routines may not be sufficient to ameliorate disease states effectively.
